Ironwood Pharmaceuticals Inc (IRWD) — Strategic Asset Allocation Index
Ironwood Pharmaceuticals Inc (IRWD) has a Strategic Asset Allocation Index of 0.9% as of March 2023. Strategic assets (PP&E of $6.01 Million plus long-term investments of $-) total $6.01 Million, measured against net assets of $706.85 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Ironwood Pharmaceuticals Inc Strategic Asset Allocation Index (2010–2022)
This chart shows how Ironwood Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 11 annual periods from 2010 to 2022. As of March 2023, the index stands at 0.9%, representing strategic assets of $6.01 Million against net assets of $706.85 Million USD. Explore IRWD cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Ironwood Pharmaceuticals Inc (2010–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Ironwood Pharmaceuticals Inc from 2010 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see IRWD stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.2% | $20.88 Million | $6.29 Million | $14.59 Million | $652.38 Million | ▼ -4.5 pp |
| 2021 | 7.7% | $46.92 Million | $22.93 Million | $24.00 Million | $605.91 Million | ▼ -64.7 pp |
| 2020 | 72.5% | $45.40 Million | $8.93 Million | $36.47 Million | $62.64 Million | ▼ -1201.5 pp |
| 2017 | 1274.0% | $125.46 Million | $17.27 Million | $108.19 Million | $9.85 Million | ▲ +1044.6 pp |
| 2016 | 229.4% | $153.03 Million | $20.51 Million | $132.52 Million | $66.72 Million | ▲ +116.3 pp |
| 2015 | 113.1% | $107.54 Million | $21.07 Million | $86.47 Million | $95.12 Million | ▲ +79.4 pp |
| 2014 | 33.7% | $29.83 Million | $29.83 Million | $- | $88.55 Million | ▼ -64.1 pp |
| 2013 | 97.8% | $37.38 Million | $37.38 Million | $- | $38.23 Million | ▲ +71.7 pp |
| 2012 | 26.1% | $37.54 Million | $37.54 Million | $- | $144.05 Million | ▼ -4.6 pp |
| 2011 | 30.6% | $33.62 Million | $33.62 Million | $- | $109.86 Million | ▲ +9.1 pp |
| 2010 | 21.5% | $34.37 Million | $34.37 Million | $- | $159.55 Million | — |